The series-parallel circuit in the treatment of fulminant hepatitis

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 2, 2004, Pages 153-159

  Nakae, Hajime ^a   Yonekawa, Chikara ^a   Moon, Sunkwi ^a   Tajimi, Kimitaka ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Continuous hemodiafiltration; Plasma exchange; Series parallel circuit

Indexed keywords

BILIRUBIN; CITRIC ACID; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD FILTRATION; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; DIAFILTRATION; FEMALE; HEMODIALYSIS; HEPATITIS; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

ADULT; AGED; BILIRUBIN; CITRIC ACID; CYTOKINES; FEMALE; HEMODIAFILTRATION; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PLASMA EXCHANGE; TREATMENT OUTCOME;

EID: 2942748115     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2003.00125.x     Document Type: Article

References (13)

1. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 1996;20:1169-72.
2. Hirasawa H, Sugai T, Oda S et al. Efficacy and limitation of apheresis therapy in critical care. Ther Apher 1997;1:228-32.
3. Nakae H, Yonekawa C, Wada H, Asanuma Y, Sato T, Tanaka H. Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure. Ther Apher 2001;5:471-5.
4. Nakae H, Asanuma Y, Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher 2002;6:419-24.
5. Sutton DM, Nair RC, Rock G. Complications of plasma exchange. Transfusion 1989;29:124-7.
6. Saibara T, Maeda T, Onishi S, Yamamoto Y. Plasma exchange and the arterial blood ketone body ratio in patients with acute hepatic failure. J Hepatol 1994;20:617-22.
7. Iwai H, Nagaki M, Naito T et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998;26:873-6.
8. Nakae H, Yonekawa C, Narita K, Endo S. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Molec Pathol Pharmacol 2001;109:65-72.
9. Okamura H, Tsutsi H, Komatsu T et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
10. Nakae H, Narita K, Endo S. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure. J Crit Care 2001;16:59-63.
11. Nakae H, Zheng YJ, Wada H, Tajimi K, Endo S. Involvement of IL-18 and soluble Fas in patients with postoperative hepatic failure. Eur Surg Res 2003;35:61-6.
12. Shito M, Tilles AW, Tompkins RG, Yarmush ML, Toner M. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. J Surg Res 2003;111:53-62.
13. Morsiani E, Pazzi P, Puviani AC et al. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002;25:192-202.